Current Value of Holding

$987 Million

Shares

25.7 Million

% of Portfolio

0.73%

Average Buy Price

$38.6

Avg closing price
Price range

36 PRIMECAP Management GSK Plc Trades

PRIMECAP Management's position in GSK Plc is currently worth $987 Million. That's 0.73% of their equity portfolio (39th largest holding). The investor owns 1.25% of the outstanding GSK Plc stock. The first GSK Plc trade was made in Q1 2013. Since then PRIMECAP Management bought shares eleven more times and sold shares on 24 occasions. The investor's estimated purchase price is $992 Million, resulting in a loss of 0.5%.

Avg closing price
Price range
Increased shares by 1.8% (+446 Thousand shares) Q1 2025
Avg closing price $36.51
Price range $32.08 - $40.39
Increased shares by 70.1% (+10.4 Million shares) Q4 2024
Avg closing price $35.92
Price range $33.35 - $40.30
Increased shares by 2.4% (+342 Thousand shares) Q3 2024
Avg closing price $40.92
Price range $38.21 - $44.26
Increased shares by 13.9% (+1.77 Million shares) Q2 2024
Avg closing price $42.07
Price range $38.50 - $45.78
Increased shares by 5.4% (+649 Thousand shares) Q1 2024
Avg closing price $41.24
Price range $37.51 - $43.58
Increased shares by 0.3% (+30.6 Thousand shares) Q4 2023
Avg closing price $35.90
Price range $34.17 - $37.56
Increased shares by 2.4% (+287 Thousand shares) Q3 2023
Avg closing price $35.49
Price range $33.81 - $38.07
Increased shares by 19.2% (+1.9 Million shares) Q2 2023
Avg closing price $35.87
Price range $33.60 - $38.32
Increased shares by 162.1% (+6.11 Million shares) Q1 2023
Avg closing price $34.99
Price range $33.50 - $36.43
Increased shares by 753.7% (+3.32 Million shares) Q4 2022
Avg closing price $33.31
Price range $30.00 - $37.92
Sold 20.0% shares (-110 Thousand shares) Q3 2022
Avg closing price $36.31
Price range $28.66 - $43.91
Sold 1.4% shares (-7.9 Thousand shares) Q2 2021
Avg closing price $38.44
Price range $35.82 - $40.66
Sold 0.6% shares (-3.2 Thousand shares) Q4 2019
Avg closing price $44.50
Price range $41.19 - $47.32
Sold 0.4% shares (-2.1 Thousand shares) Q3 2019
Avg closing price $41.15
Price range $39.68 - $42.68
Sold 2.1% shares (-12.3 Thousand shares) Q2 2019
Avg closing price $40.14
Price range $38.64 - $41.88
Sold 31.6% shares (-267 Thousand shares) Q4 2018
Avg closing price $39.40
Price range $37.07 - $41.87
Sold 19.5% shares (-204 Thousand shares) Q3 2018
Avg closing price $40.64
Price range $38.99 - $41.87
Sold 2.3% shares (-25.1 Thousand shares) Q1 2018
Avg closing price $37.26
Price range $35.49 - $39.38
Sold 0.3% shares (-3 Thousand shares) Q4 2017
Avg closing price $36.96
Price range $34.66 - $41.10
Sold 1.7% shares (-18.5 Thousand shares) Q2 2017
Avg closing price $42.65
Price range $40.68 - $44.37

News about GSK Plc - ADR and PRIMECAP Management

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!